PubRank

Marc-André Roy

Author PubWeight™ 39.53‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 How prevalent are anxiety disorders in schizophrenia? A meta-analysis and critical review on a significant association. Schizophr Bull 2009 1.69
2 Retinal response to light in young nonaffected offspring at high genetic risk of neuropsychiatric brain disorders. Biol Psychiatry 2009 1.53
3 Development of an atherogenic metabolic risk factor profile associated with the use of atypical antipsychotics. J Clin Psychiatry 2004 1.49
4 Fast, systematic, and continuous delirium assessment in hospitalized patients: the nursing delirium screening scale. J Pain Symptom Manage 2005 1.47
5 Psychoactive medications and risk of delirium in hospitalized cancer patients. J Clin Oncol 2005 1.17
6 Opioid medications and longitudinal risk of delirium in hospitalized cancer patients. Cancer 2007 1.04
7 Long-acting injectable antipsychotics: evidence of effectiveness and use. Can J Psychiatry 2013 0.97
8 Shared neurocognitive dysfunctions in young offspring at extreme risk for schizophrenia or bipolar disorder in eastern quebec multigenerational families. Schizophr Bull 2008 0.97
9 Chromosome 13q13-q14 locus overlaps mood and psychotic disorders: the relevance for redefining phenotype. Eur J Hum Genet 2009 0.93
10 Assessment of empathy in first-episode psychosis and meta-analytic comparison with previous studies in schizophrenia. Psychiatry Res 2010 0.93
11 Adiposity and eating behaviors in patients under second generation antipsychotics. Obesity (Silver Spring) 2008 0.91
12 Verbal and visual memory impairments among young offspring and healthy adult relatives of patients with schizophrenia and bipolar disorder: selective generational patterns indicate different developmental trajectories. Schizophr Bull 2010 0.91
13 Association between psychoactive medications and delirium in hospitalized patients: a critical review. Psychosomatics 2005 0.90
14 Impact on delirium detection of using a sensitive instrument integrated into clinical practice. Gen Hosp Psychiatry 2005 0.88
15 [Long-acting injectable antipsychotics: an expert opinion from the Association des médecins psychiatres du Québec]. Can J Psychiatry 2011 0.88
16 Replication of linkage with bipolar disorder on chromosome 16p in the Eastern Quebec population. Am J Med Genet B Neuropsychiatr Genet 2008 0.87
17 Creation and pilot testing of StrokEngine: a stroke rehabilitation intervention website for clinicians and families. J Rehabil Med 2008 0.87
18 Cluster analysis of cognitive deficits may mark heterogeneity in schizophrenia in terms of outcome and response to treatment. Eur Arch Psychiatry Clin Neurosci 2013 0.87
19 An Exploratory, Open-Label, Randomized Trial Comparing Risperidone Long-Acting Injectable with Oral Antipsychotic Medication in the Treatment of Early Psychosis. Clin Schizophr Relat Psychoses 2013 0.86
20 Long-acting injectable antipsychotics: recommendations for clinicians. Can J Psychiatry 2013 0.85
21 A qualitative study of experiences with and perceptions regarding long-acting injectable antipsychotics: part II-physician perspectives. Can J Psychiatry 2013 0.85
22 Familiarity and recollection processes in patients with recent-onset schizophrenia and their unaffected parents. Psychiatry Res 2009 0.85
23 Mentalizing in first-episode psychosis. Psychiatry Res 2012 0.84
24 Endogenous cannabinoids in patients with schizophrenia and substance use disorder during quetiapine therapy. J Psychopharmacol 2008 0.84
25 Impact of social anxiety on social cognition and functioning in patients with recent-onset schizophrenia spectrum disorders. Schizophr Res 2013 0.83
26 Schizophrenia patients with polydipsia and water intoxication are characterized by greater severity of psychotic illness and a more frequent history of alcohol abuse. Schizophr Res 2010 0.83
27 Follow-up of a major psychosis linkage site in 13q13-q14 reveals significant association in both case-control and family samples. Biol Psychiatry 2013 0.83
28 Time perception disorders are related to working memory impairment in schizophrenia. Psychiatry Res 2012 0.82
29 Detection of phenotype modifier genes using two-locus linkage analysis in complex disorders such as major psychosis. Hum Hered 2012 0.81
30 Anhedonia and social adaptation predict substance abuse evolution in dual diagnosis schizophrenia. Am J Drug Alcohol Abuse 2008 0.81
31 Processing spatial-temporal information in recent-onset schizophrenia: the study of short-term memory and its susceptibility to distraction. Brain Cogn 2007 0.81
32 Quetiapine in patients with comorbid schizophrenia-spectrum and substance use disorders: an open-label trial. Curr Med Res Opin 2006 0.81
33 Young offspring at genetic risk of adult psychoses: the form of the trajectory of IQ or memory may orient to the right dysfunction at the right time. PLoS One 2011 0.81
34 A new strategy for linkage analysis under epistasis taking into account genetic heterogeneity. Hum Hered 2009 0.80
35 [Improving detection and treatment of early psychosis in Québec: the Quebec association of early psychosis (l'Association québécoise des programmes pour premiers épisodes psychotiques, AQPPEP), sees to it]. Sante Ment Que 2007 0.78
36 A factor analysis of the Strauss and Carpenter revised outcome criteria scale: a validation of the French translation. J Nerv Ment Dis 2004 0.78
37 Chromosome 1q12-q22 linkage results in eastern Québec families affected by schizophrenia. Am J Med Genet 2002 0.78
38 Applying Motivational Interviewing to the initiation of long-acting injectable atypical antipsychotics. Australas Psychiatry 2012 0.77
39 An examination of the relative contribution of saturation and selective attention to memory deficits in patients with recent-onset schizophrenia and their unaffected parents. J Abnorm Psychol 2010 0.77
40 Symptom dimensions as alternative phenotypes to address genetic heterogeneity in schizophrenia and bipolar disorder. Eur J Hum Genet 2012 0.76
41 A qualitative study of experiences with and perceptions regarding long-acting injectable antipsychotics: Part I-patient perspectives. Can J Psychiatry 2013 0.76
42 Improvement of metabolic risk profile under second-generation antipsychotics: a pilot intervention study. Can J Psychiatry 2009 0.76
43 The role of recollection in source memory: an examination of schizophrenia patients and their first-degree relatives. Brain Cogn 2010 0.76
44 A comment on "Cognitive deficits in relatives of patients with schizophrenia: a meta-analysis" from a cognitive neuropsychological perspective. Schizophr Res 2006 0.75
45 Haloperidol decanoate doses of 200, 100, or 50 mg/month reduced symptomatic exacerbations more than a 25 mg/month dose in schizophrenia. Evid Based Ment Health 2002 0.75
46 [Cognitive-behavioural therapy in early psychosis: an open study in a clinical setting]. Can J Psychiatry 2011 0.75
47 [Genetics of schizophrenia and bipolar disorder: recent success of linkage studies with evidence of specific and shared susceptibility loci]. Med Sci (Paris) 2003 0.75
48 Insights from the examination of verbal and spatial memory errors in relation to clinical symptoms of patients with recent-onset schizophrenia. Cogn Neuropsychiatry 2009 0.75
49 A pilot feasibility study of an extension of the acquaintanceship recruitment procedure in recent-onset psychosis. J Nerv Ment Dis 2005 0.75